Streetbeat News

Price Targets

AA

HSBC analyst Jonathan Brandt has initiated coverage on Alcoa (NYSE:AA) with a Hold rating and set a price target of $29 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 07, 2023 | 11:12 am

BIO

UBS analyst Dan Leonard has initiated coverage on Bio-Rad Laboratories (NYSE:BIO) with a Buy rating and set a price target of $395.

Portfolio Pulse from Benzinga Newsdesk

December 07, 2023 | 11:10 am

CERT

UBS analyst Dan Leonard has initiated coverage on Certara (NASDAQ:CERT) with a Neutral rating and set a price target of $17.

Portfolio Pulse from Benzinga Newsdesk

December 07, 2023 | 11:09 am

TECH

UBS analyst Dan Leonard has initiated coverage on Bio-Techne (NASDAQ:TECH) with a Buy rating and set a price target of $80 for the stock.

Portfolio Pulse from Benzinga Newsdesk

December 07, 2023 | 11:07 am

BRZE

Barclays analyst Ryan Macwilliams has maintained an Overweight rating on Braze (NASDAQ:BRZE) and increased the price target from $65 to $80.

Portfolio Pulse from Benzinga Newsdesk

December 07, 2023 | 11:07 am

SLG

Barclays analyst Anthony Powell has maintained an Underweight rating on SL Green Realty (NYSE:SLG) but increased the price target from $26 to $35.

Portfolio Pulse from Benzinga Newsdesk

December 07, 2023 | 11:06 am

FLGT

UBS analyst Dan Leonard has initiated coverage on Fulgent Genetics (NASDAQ:FLGT) with a Neutral rating and set a price target of $35.

Portfolio Pulse from Benzinga Newsdesk

December 07, 2023 | 11:06 am

OLN

Deutsche Bank analyst David Begleiter has initiated coverage on Olin Corporation (NYSE:OLN) with a Hold rating and set a price target of $52.

Portfolio Pulse from Benzinga Newsdesk

December 07, 2023 | 11:04 am

CERE

Piper Sandler analyst David Amsellem has downgraded Cerevel Therapeutics Holdings (CERE) from Overweight to Neutral, while increasing the price target from $33 to $45. This reflects a more cautious stance on the stock's current valuation, despite the raised price target suggesting a belief in the company's potential for growth.

Portfolio Pulse from Benzinga Newsdesk

December 07, 2023 | 11:00 am

FEAM

B. Riley Securities analyst Matthew Key has downgraded 5E Advanced Materials (FEAM) from Buy to Neutral and reduced the price target from $4 to $2.5.

Portfolio Pulse from Benzinga Newsdesk

December 07, 2023 | 10:52 am